Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma.
Tao YanFang LiuJiajia GaoHaizhen LuJianqiang CaiXiaohang ZhaoYulin SunPublished in: Cancer cell international (2019)
The deregulation of RUVBL2 in HCC is influenced at the genomic, epigenetic and transcriptional levels. Our findings highlight the potential roles of RUVBL2 as a promising prognostic marker as well as a therapeutic target for HCC.